How Will The Chlamydia Infection Diagnostics Market Expand At A CAGR Of 11.4% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Chlamydia Infection Diagnostics Market Valuation Change Between Now And 2029?
The market for diagnosing chlamydia infections has seen a robust expansion in the recent past. The market, which stands at $1.25 billion in 2024, is anticipated to surge to $1.4 billion in 2025, registering a compound annual growth rate (CAGR) of 11.6%. The exceptional growth during the historical period is a result of heightened awareness and education, government subsidies, a rising incidence of sexually transmitted infections (STIs) alongside improved accessibility to healthcare services.
In the coming years, the chlamydia infection diagnostics market is anticipated to witness swift growth. The market value is projected to reach $2.15 billion by 2029, manifesting a compound annual growth rate (CAGR) of about 11.4%. The escalation during the forecast period can be credited to multiple factors such as the escalating demand for swift testing, increasing support from global agencies, governmental interventions, the surge in the need for dependable and swift testing, and the growing incidence of chlamydia infections. Major anticipated trends throughout this period comprise advancements in the realm of molecular diagnostics, the broadening of point-of-care testing (POCT), the incorporation of digital health technologies, emphasis on population screening and public health agendas, breakthrough technologies, and innovations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18296&type=smp
What Growth-Enabling Forces Are Impacting The Chlamydia Infection Diagnostics Market?
The increasing concentration on preventive healthcare is anticipated to drive the growth of the chlamydia infection diagnostics market. Preventive healthcare is centered on disease prevention through regular doctor visits, inoculations, and lifestyle changes, rather than treating health conditions once they occur. The emphasis on preventive healthcare is aimed at reducing healthcare expenses, enhancing quality of life, and averting chronic diseases through proactive health measures and early detection. Chlamydia diagnostics greatly benefit from preventive healthcare, thanks to the focus on education, routine screening, and early diagnostics, which collectively mitigate the transference and severity of chlamydia infections. For instance, the National Health Service (NHS), a publicly-funded UK-based healthcare organization, reported about 23.02 million diagnostic tests were carried out in March 2023, denoting an increase of 223,100 tests from March 2022. Similarly, the count of patients in line for an essential diagnostic test rose to 16.28 million in March 2023, escalading by 59,400 compared to March 2022. Thus, the rising emphasis on preventive healthcare is driving the progress of the chlamydia infection diagnostics market.
What Are The Main Segment Classifications In The Chlamydia Infection Diagnostics Market?
The chlamydia infection diagnosticsmarket covered in this report is segmented –
1) By Test Type: Culture Test; Nucleic Acid Amplification Test (NAAT); Direct Fluorescent Antibody Test; Serology Test; Other Test Types
2) By Type Of Infections: Genital Chlamydia Infection; Rectal Chlamydia Infection; Ocular Chlamydia Infection
3) By Application: Hospitals; Specialty Clinics; Diagnostic Centers
4) By End User: Diagnostics; Therapeutics
Subsegments:
1) By Culture Test: Cell Culture; Egg Culture
2) By Nucleic Acid Amplification Test (NAAT): PCR-Based Test; LAMP-Based Test
3) By Direct Fluorescent Antibody Test: Direct Fluorescent Antibody Staining; Direct Fluorescent In-Situ Hybridization
4) By Serology Test: Immunoassays; Enzyme Immunoassay (EIA)
5) By Other Test Types: Enzyme-Linked Immunosorbent Assay (ELISA); Hybrid Capture Test
Which Emerging Trends Are Reshaping The Chlamydia Infection Diagnostics Market Landscape?
Leading enterprises active in the chlamydia infection diagnosis industry are centering their efforts on creating avant-garde products such as molecular point-of-care testing platforms, to secure a benefit over their competitors. These platforms are engineered to identify and scrutinize specific nucleic acids (DNA or RNA) of pathogens right at the patient’s care site. For example, in May 2024, US-based biotechnology firm Sherlock Biosciences publicized the development of the Sherlock test. This is one of the inaugural molecular tests that can be disposed of after checking for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG). The results from these diagnostic procedures, which analyze DNA and RNA from self-collected penile meatal or vaginal swabs, are typically available in less than half an hour.
Which Firms Are Driving Innovation Within The Chlamydia Infection Diagnostics Market?
Major companies operating in the chlamydia infection diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Cepheid, Meridian Bioscience Inc., Sekisui Diagnostics, Copan Diagnostics
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Chlamydia Infection Diagnostics Market?
North America was the largest region in the chlamydia infection diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chlamydia infection diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18296&type=smp
Browse Through More Reports Similar to the Global Chlamydia Infection Diagnostics Market 2025, By The Business Research Company
Urinary Tract Infection Treatment Global Market Report 2025
Preoperative Infection Prevention And Wound Cleansing Devices Global Market Report 2025
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
